Indianapolis Today

By the People, for the People

Stock Markets

Recent news

Elevance Health Receives $387.40 Consensus Target Price from Analysts

The health insurance provider's stock is rated 'Moderate Buy' by 22 research firms.

Nordea Investment Management Trims Elevance Health Stake

Institutional investor sells over 68,000 shares of the health insurance company

Eli Lilly Shares Purchased by Investment Firm

Neville Rodie & Shaw Inc. boosts stake in pharmaceutical giant

AIA Group Ltd Boosts Stake in Eli Lilly and Company

Institutional investor increases holdings in pharmaceutical giant by 34.9% in Q3

Wall Street Zen Downgrades Eli Lilly and Company (NYSE:LLY) to Buy

Analysts cut rating from "strong-buy" to "buy" on pharmaceutical giant

Tudor Investment Corp ET AL Boosts Stake in CNO Financial Group

Hedge fund increases ownership in financial services provider by 16.5% in Q3

Groupama Asset Managment Reduces Stake in Eli Lilly and Company

The investment firm sold 15,395 shares of the pharmaceutical giant in the third quarter.

LRT Capital Management LLC Buys Stake in Eli Lilly

Investment firm acquires 861 shares of pharmaceutical giant in Q3

Kite Realty Group Trust Sees Institutional Investor Sell-Off

Algert Global LLC reduces stake in real estate investment trust by nearly 47%

Moneta Group Boosts Eli Lilly Stake by 16%

Investment firm increases holdings in pharmaceutical giant during Q3 2026

Moore Capital Management Boosts Elevance Health Stake

Institutional investor increases holding in health insurance giant by over 149%

Loews Corp Boosts Elevance Health Stake by 107.5%

Institutional investor Loews Corp significantly increased its holdings in health insurance provider Elevance Health, Inc. in the third quarter.

Bank of Nova Scotia Boosts Elevance Health Stake by 136%

The Canadian bank now owns over 70,000 shares of the healthcare company.

Fred Alger Management Reduces Eli Lilly Holdings

Investment firm cuts stake in pharmaceutical giant by over 39%

Hyperion Capital Advisors Boosts Elevance Health Stake

Investment firm increases holdings in major health insurance provider by nearly 47%

Fred Alger Management Reduces Stake in Eli Lilly

Institutional investor cuts holdings in pharmaceutical giant by over 39%

Elevation Point Wealth Partners Boosts Eli Lilly Holdings

Institutional investor increases stake in pharmaceutical giant by over 400%

Clark Capital Management Group Boosts Stake in CNO Financial

Investment firm increases position in insurance provider by 16.7% in Q3

Calydon Capital Trims Stake in Eli Lilly and Company

Hedge fund reduces position in pharmaceutical giant by over 50%

Elevance Health Shares Sold by Cannell & Spears LLC

Institutional investor reduces stake in health benefits company